Pharma Companies
With a ₹2,200-a-week price tag, Ozempic enters India as Novo Nordisk steps up its obesity bet
Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s plans to lead India’s fast-growing obesity drug market, and how it is navigating competition and upcoming generic threats. Novo's India market strategy for Ozempic based on an interview is here.
5 min read12 Dec 2025French drugmaker Servier firms up India focus with manufacturing tie-ups, trial plans
The company recently received market authorization from the Indian drug regulator for its drug Vorasidenib, a first-in-class, oral therapy for adults or children over 12 with grade-2 gliomas or types of brain cancer, with specific genetic mutations.
2 min read10 Dec 2025Dr Reddy’s wins Delhi HC nod to export semaglutide to non-patent markets
The development is expected to have significant implications for India’s generic drugmakers, which are raring to enter the fast-growing anti-obesity drug market.
4 min read2 Dec 2025Divi’s Laboratories, Piramal Pharma to Laurus Labs: Why are pharma stocks skyrocketing today?
Divi’s Laboratories, Piramal Pharma, Wockhardt, Cipla, Laurus Labs, Aurobindo Pharma, Glenmark Pharmaceuticals, Dr Reddy’s Laboratories were among the top gainers in the Nifty Pharma index.
1 min read10 Oct 2025Pharma deals are surging. But the biggest drugmakers are holding back.
While India-focused drugmakers are ramping up dealmaking to expand portfolios, access key therapies, and gain scale, US-focused giants like Sun Pharma, Cipla, and Dr. Reddy’s are holding back, opting for selective acquisitions to expand in other geographies.
5 min read9 Oct 2025Rubicon Research IPO: ₹1377 crore issue opens in 2 days; 10 key points you must know from RHP
Rubicon Research's IPO opens for subscription on October 9 and closes on October 13, with a fresh issue of shares aggregating ₹500 crore and an offer for sale of ₹877.50 crore. Listing is expected on October 16 on NSE and BSE.
3 min read6 Oct 2025Anlon Healthcare IPO to open on Tuesday: 10 key things to know from RHP before you subscribe to ₹121 crore issue
The Anlon Healthcare IPO will be available from August 26-29, with plans to raise ₹121 crore. The company specializes in high-purity pharmaceutical intermediates and has a global presence, supplying products to over 15 countries.
3 min read25 Aug 2025Eli Lilly launches Mounjaro pen in India as obesity drug race heats up
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to capture India’s growing anti-obesity market as Novo Nordisk pushes Wegovy.
2 min read13 Aug 2025Top Losers and Gainers on Aug 01: PNB Housing Finance, IIFL Finance, Reliance Power, Swan Energy among top losers today
The Nifty closed the session down 0.82% at 24,565 points, extending its weekly losses for the fifth straight week with another 1.13% decline. The S&P BSE Sensex also ended lower by 0.72% at 80,599, finishing the week nearly 1% down. This marks the longest weekly losing streak.
4 min read1 Aug 2025Lilly’s Zepbound faces a potential weight-loss rival. It’s made by a Chinese biotech
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring to U.S. biopharma.
4 min read16 Jul 2025Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.